Procoagulant phospholipid membrane of activated platelets

Activated platelets and their associated procoagulant phospholipid membranes serve as the critical platform for the assembly of coagulation factor complexes, such as the tenase and prothrombinase complexes (Lentz, 2003, Biochemistry). Upon activation by stimuli like thrombin or collagen, platelets undergo a shape change and a flip-flop of their plasma membrane, exposing anionic phospholipids—primarily phosphatidylserine (PS)—on the outer leaflet (Heemskerk et al., 2013, Trends in Molecular Medicine). This PS-exposed surface provides the necessary environment for the calcium-dependent binding of vitamin K-dependent clotting factors, which dramatically accelerates thrombin generation (Zwaal & Schroit, 1997, Blood). In pathological states, this process leads to arterial and venous thrombosis, contributing to myocardial infarction and stroke. Therapeutic and diagnostic strategies targeting this surface include the use of Annexin A5 derivatives, which bind with high affinity to PS to either image thrombi or potentially shield the surface from further coagulation assembly (Schutters & Reutelingsperger, 2010, Apoptosis). Additionally, drugs like abciximab target specific receptors that become active on these membranes, such as the glycoprotein IIb/IIIa complex, to prevent platelet aggregation.

Other names

Activated platelet surfaceProcoagulant surfacePhosphatidylserine-exposed membranePlatelet procoagulant membrane

Binding to anionic phospholipids (specifically phosphatidylserine) or activation-induced conformational changes in surface receptors (e.g., integrin alpha-IIb/beta-3) to inhibit thrombus formation or facilitate thrombus detection.